17 June 2020>: Clinical Research
Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery
Lucia Kendrová 1ABCDEFG* , Wioletta Mikuľáková 1ABEG , Katarína Urbanová 1BEF , Štefánia Andraščíková 2CDG , Silvia Žultáková 2EFG , Peter Takáč 3CDE , Yuriy Peresta 1DEFDOI: 10.12659/MSM.924071
Med Sci Monit 2020; 26:e924071
Table 4 Predictors of achieving a significant improvement in QoL (reduction of LLL).
Δ LYMQOL | R2 | F | P | Age | Reduction of LLL | ||||
---|---|---|---|---|---|---|---|---|---|
b | β | P | b | β | P | ||||
Δ Symptoms | 0.031 | 0.753 | 0.477 | −0.003 | −0.077 | 0.096 | 0.018 | 0.156 | 0.283 |
Δ Body image/appearance | 0.021 | 0.510 | 0.604 | 0.003 | 0.092 | 0.529 | 0.011 | 0.013 | 0.423 |
Δ Function | 0.136 | 0.440 | 0.647 | 0.006 | 0.133 | 0.361 | 0.003 | 0.029 | 0.843 |
Δ Mood | 0.131 | 0.412 | 0.664 | −0.004 | −0.131 | 0.370 | 0.000 | 0.005 | 0.970 |
Δ Overall QoL | 0.287 | 2.106 | 0.133 | −0.020 | −0.258 | 0.071 | −0.028 | −0.134 | 0.342 |
Δ Pain | 0.094 | 0.210 | 0.811 | 0.009 | 0.090 | 0.538 | −0.006 | −0.024 | 0.867 |
QoL – quality of life; LLL – lower limb lymphedema; LYMQOL – Lymphoedema Quality of Life. |